Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag
12:51pm, Wednesday, 31'st Jan 2024
Bristol Myers' (BMY) two sBLAs for Breyanzi in relapsed/refractory follicular lymphoma and relapsed/refractory mantle cell lymphoma receive FDA acceptance and priority review.
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
01:52pm, Tuesday, 30'th Jan 2024
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
Wall Street's Insights Into Key Metrics Ahead of Bristol Myers (BMY) Q4 Earnings
10:21am, Tuesday, 30'th Jan 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Bristol Myers (BMY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for t
Bristol Myers Squibb (BMY) Increases Yet Falls Behind Market: What Investors Need to Know
06:46pm, Monday, 29'th Jan 2024
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $49.87, denoting a +0.34% change from the preceding trading day.
Pharma industry to get US government price cut proposals by Thursday
11:35am, Monday, 29'th Jan 2024
Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for discounts it is seeking on 10 high-cost medicines, an important step in the Medicare health program's
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
12:01pm, Friday, 26'th Jan 2024
Healthcare stocks trudged through what was a terrible 2023 for the sector. While the S&P 500 rose by 24% during 2023, the healthcare sector managed paltry returns of 0.3%.
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
11:06am, Friday, 26'th Jan 2024
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What You Need to Know Ahead of Bristol-Myers (BMY) Q4 Earnings
11:36am, Thursday, 25'th Jan 2024
Investors are likely to focus on Opdivos demand, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) reports Q4 results.
Dividend Harvesting Portfolio Week 151: $15,100 Allocated, $1,331.13 In Projected Dividends
09:00am, Thursday, 25'th Jan 2024
Dividend Harvesting Portfolio Week 151: $15,100 Allocated, $1,331.13 In Projected Dividends
7 Beaten-Down Value Stocks Poised for an Epic Turnaround
05:06pm, Tuesday, 23'rd Jan 2024
With the S&P 500 reaching new highs last week, investors appear to be taking an optimistic view of the overall stock market. However, not all stocks are participating in this rally.
Bristol-Meyers Stock Seeing Layers of Pressure
02:48pm, Tuesday, 23'rd Jan 2024
After eight-straight monthly losses starting in April 2023, the shares of pharmaceutical concern Bristol-Meyers Squibb Co (NYSE:BMY) started to rebound in December, though were swiftly rejected by th
FDA Demands "Boxed Warning" to CAR T-Cell Therapy Labels
09:10am, Tuesday, 23'rd Jan 2024
The FDA directs companies like NVS, BMY, GILD and others to add "boxed warning" to the labels of their CAR T-cell immunotherapies after it identified adverse events.
BMY: Might Be Approaching A Bottom In 2024
08:02am, Tuesday, 23'rd Jan 2024
BMY reports in Q4 results next week, below I discuss what investors should consider heading into earnings. The recent $20bn (estimated) acquisition spree in Q4 may have signalled a weak drug pipeline
Bristol Myers Squibb (BMY) Stock Drops Despite Market Gains: Important Facts to Note
06:56pm, Monday, 22'nd Jan 2024
The latest trading day saw Bristol Myers Squibb (BMY) settling at $49.57, representing a -1.08% change from its previous close.
Bristol Myers Squibb (BMY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:34pm, Tuesday, 16'th Jan 2024
Bristol Myers Squibb (BMY) closed at $50 in the latest trading session, marking a -0.62% move from the prior day.
